BRAF V600E positive papillary thyroid carcinoma (TERT and TP53 mutation coexistence excluded): Correlation of clinicopathological features and the extent of surgical treatment and its complications
Journal of Applied Biomedicine · 2024
DOI: 10.32725/jab.2024.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Biomedicine, 2024. Verfasst von Jiri Hlozek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Military University Hospital Prague, Department of Otorhinolaryngology and Maxillofacial Surgery, Prague, Czech Republic. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Thyroid Cancer, Papillary, Thyroid Neoplasms, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Defense of the Czech Republic, Ministry of Health of the Czech Republic, MH CZ-DRO.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Military University Hospital Prague, Department of Otorhinolaryngology and Maxillofacial Surgery, Prague, Czech Republic.
- Charles University, Third Faculty of Medicine, Prague, Czech Republic.
- Masaryk University, St. Anne's University Hospital, Medical Faculty Brno, Department of Otorhinolaryngology and Head and NeckSurgery, Brno, Czech Republic.
- Institute of Endocrinology, Department of Molecular Endocrinology, Prague, Czech Republic.
- Military University Hospital, Department of Pathology, Prague, Czech Republic.
- Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, The Fingerland Department of Pathology, Hradec Kralove, Czech Republic.
Förderung
- Ministry of Defense of the Czech Republic
- Ministry of Health of the Czech Republic
- MH CZ-DRO
Zitieren
APA
Hlozek, J., Rotnagl, J., Holy, R., Hlozkova, T., Pekova Bulanova, B., Kuklikova, V., Bendlova, B., Soukup, J., Hrabal, P., & Astl, J. (2024). BRAF V600E positive papillary thyroid carcinoma (TERT and TP53 mutation coexistence excluded): Correlation of clinicopathological features and the extent of surgical treatment and its complications. Journal of Applied Biomedicine. https://doi.org/10.32725/jab.2024.025
Vancouver
Hlozek J, Rotnagl J, Holy R, Hlozkova T, Pekova Bulanova B, Kuklikova V, et al. BRAF V600E positive papillary thyroid carcinoma (TERT and TP53 mutation coexistence excluded): Correlation of clinicopathological features and the extent of surgical treatment and its complications. Journal of Applied Biomedicine. 2024. doi:10.32725/jab.2024.025
BibTeX
@article{Hlozek2024,
author = {Hlozek, Jiri and Rotnagl, Jan and Holy, Richard and Hlozkova, Tereza and Pekova Bulanova, Barbora and Kuklikova, Vlasta and Bendlova, Bela and Soukup, Jiri and Hrabal, Petr and Astl, Jaromir},
title = {BRAF V600E positive papillary thyroid carcinoma (TERT and TP53 mutation coexistence excluded): Correlation of clinicopathological features and the extent of surgical treatment and its complications},
journal = {Journal of Applied Biomedicine},
year = {2024},
doi = {10.32725/jab.2024.025}
}
EUVIMED